LabStyle Innovations Corp. (OTCQB:DRIO) said today it is rebranding, shifting its corporate moniker to DarioHealth Corp.
The Boston-based company said the new name reflects the “company’s growth and development in the digital health and mHealth space,” and added that it will continue to trade on Nasdaq under the ticker “DRIO.”
“The healthcare world is changing, and we believe we have the right solution to disrupt the industry and revolutionize the way users manage their health. Health is no longer about disease-care; it’s about personalization and lifestyle management. We are committed to advancing this movement by putting individuals first and delivering innovative, disruptive, user-centric digital health solutions – in all aspects of healthcare. The new name – DarioHealth – is paramount in achieving this goal,” CEO Erez Raphael said in a press release.
The new name will go into effect tomorrow, and will be implemented across all of the company’s products and services through the rest of the calendar year.
“Dario is being embraced by users all over the world, and has already established a strong and recognizable brand within the diabetes management space. Our corporate rebranding is an important step to better align our solutions to the larger and more rapidly growing digital health space. Our name change reflects our strategy and goals as an organization and will help us extend our offerings for prevention, wellness and disease management to a larger and more diverse global market,” CEO Raphael said in prepared remarks.
Last December, DarioHealth won FDA 510(k) clearance for its Dario blood glucose monitoring system, including its blood test strips and the Dario app for Apple (NSDQ:AAPL) iOS devices.
The company’s flagship Dario system is designed to operate around a smartphone and a small glucose meter that communicates with the phone through the audio jack, the company said. The smartphone as a central device is important to the systems functionality and ease of adopting, executive veep Todd Durniak told MassDevice.com in an interview in September.
The small plug-in monitor contains everything necessary to take blood glucose readings, which the Dario platform uploads to cloud-based storage where they can be observed, recorded and shared by caretakers, physicians and others, Durniak said.